Elysium, an innovative player in the healthcare sector, is at the forefront of integrating AI and machine learning into the healthcare and life sciences industries. Founded in 2019, the company is headquartered in Italy and is strategically positioned to revolutionize healthcare data analytics within the European market by 2026.
Central to Elysium's strategy is Medory, the first platform that enables seamless sharing of medical histories globally. This free service not only facilitates doctor-patient interactions but also allows Elysium to aggregate extensive health data, which, once anonymized, will serve as a valuable resource for medical and pharmaceutical research. By providing these high-quality datasets, Elysium aims to unlock novel insights that remain untapped by current technologies.
The company's last recorded investment was a €25.00K grant from Lazio Innova on 01 May 2021, supporting its mission to establish a data-driven, patient-centric healthcare ecosystem. Through comprehensive data aggregation and innovative product integrations, Elysium aspires to transform healthcare interactions, promoting efficient information exchange among all stakeholders.